Warning For Facebook “Like” Reflects FDA Social Media Approach

 
• By Elizabeth Crawford

FDA is revealing its views on social media use through individual enforcement actions and provisions in disparate guidances, in the absence of issuing an overarching guidance. A recent warning letter sheds light on the agency’s view of “liking” something on Facebook.

FDA is defining proper social media use in small doses, through warning letters and minor rule changes, rather than issuing comprehensive guidance, as illustrated in a recent warning that targets a company’s “likes.”

Since 2009, FDA has promised to issue guidance on how drug firms can use social media safely, but multiple delays...

More from Marketing & Advertising

More from Compliance